Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Haim

Showing results (71-80 of 116) with videos related to

Pageof 12
Sort By:
CNS Spectrums|August 19, 2016
Estimating minimal important differences for several scales assessing function and quality of life in patients with attention-deficit/hyperactivity disorderPaul Hodgkins, Andrew Lloyd, M Haim Erder, et al.
Pharmacoepidemiology and Drug Safety|May 4, 2012
Comparative effectiveness research using matching-adjusted indirect comparison: an application to treatment with guanfacine extended release or atomoxetine in children with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorderJames Signorovitch, M Haim Erder, Jipan Xie, et al.
Cardiology|September 1, 1997
Prognostic significance of infarction location in patients with recurrent myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israel Nifedipine TrialR Kornowski, U Goldbourt, H Reicher-Reiss, et al.
Oncology (Williston Park, N.Y.)|October 17, 2002
Psychological outcomes associated with anemia-related fatigue in cancer patientsJoel D Kallich, N Simon Tchekmedyian, Anne M Damiano, et al.
The American Journal of Cardiology|March 15, 1997
Comparison of short- and long-term prognosis in patients with anterior wall versus inferior or lateral wall non-Q-wave acute myocardial infarction. Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) Study GroupM Haim, H Hod, L Reisin, et al.
Infection|March 6, 2002
Norwalk virus gastroenteritis among Israeli soldiers: lack of evidence for flyborne transmissionD Cohen, S S Monroe, M Haim, et al.
Journal of Medical Economics|July 2, 2009
Treatment persistence, healthcare utilisation and costs in adult patients with major depressive disorder: a comparison between escitalopram and other SSRI/SNRIsEric Q Wu, Paul E Greenberg, Elaine Yang, et al.
The American Journal of Cardiology|March 1, 1997
Frequency and prognostic significance of high-degree atrioventricular block in patients with a first non-Q-wave acute myocardial infarction. The SPRINT Study Group. Second Prevention Reinfarction Israeli Nifedipine TrialM Haim, H Hod, E Kaplinsky, et al.
Current Medical Research and Opinion|March 29, 2011
Remission of major depressive disorder without adverse events: a comparison of escitalopram versus serotonin norepinephrine reuptake inhibitorsJames Signorovitch, Karthik Ramakrishnan, Rym Ben-Hamadi, et al.
Health and Quality of Life Outcomes|November 19, 2015
Psychometric validation of the Weiss Functional Impairment Rating Scale-Parent Report Form in children and adolescents with attention-deficit/hyperactivity disorderKavita Gajria, Mark Kosinski, Vanja Sikirica, et al.
Pageof 12

Showing results (71-80 of 116) with videos related to

Sort By:
Pageof 12
CNS Spectrums|August 19, 2016
Estimating minimal important differences for several scales assessing function and quality of life in patients with attention-deficit/hyperactivity disorderPaul Hodgkins, Andrew Lloyd, M Haim Erder, et al.
Pharmacoepidemiology and Drug Safety|May 4, 2012
Comparative effectiveness research using matching-adjusted indirect comparison: an application to treatment with guanfacine extended release or atomoxetine in children with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorderJames Signorovitch, M Haim Erder, Jipan Xie, et al.
Cardiology|September 1, 1997
Prognostic significance of infarction location in patients with recurrent myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israel Nifedipine TrialR Kornowski, U Goldbourt, H Reicher-Reiss, et al.
Oncology (Williston Park, N.Y.)|October 17, 2002
Psychological outcomes associated with anemia-related fatigue in cancer patientsJoel D Kallich, N Simon Tchekmedyian, Anne M Damiano, et al.
The American Journal of Cardiology|March 15, 1997
Comparison of short- and long-term prognosis in patients with anterior wall versus inferior or lateral wall non-Q-wave acute myocardial infarction. Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) Study GroupM Haim, H Hod, L Reisin, et al.
Infection|March 6, 2002
Norwalk virus gastroenteritis among Israeli soldiers: lack of evidence for flyborne transmissionD Cohen, S S Monroe, M Haim, et al.
Journal of Medical Economics|July 2, 2009
Treatment persistence, healthcare utilisation and costs in adult patients with major depressive disorder: a comparison between escitalopram and other SSRI/SNRIsEric Q Wu, Paul E Greenberg, Elaine Yang, et al.
The American Journal of Cardiology|March 1, 1997
Frequency and prognostic significance of high-degree atrioventricular block in patients with a first non-Q-wave acute myocardial infarction. The SPRINT Study Group. Second Prevention Reinfarction Israeli Nifedipine TrialM Haim, H Hod, E Kaplinsky, et al.
Current Medical Research and Opinion|March 29, 2011
Remission of major depressive disorder without adverse events: a comparison of escitalopram versus serotonin norepinephrine reuptake inhibitorsJames Signorovitch, Karthik Ramakrishnan, Rym Ben-Hamadi, et al.
Health and Quality of Life Outcomes|November 19, 2015
Psychometric validation of the Weiss Functional Impairment Rating Scale-Parent Report Form in children and adolescents with attention-deficit/hyperactivity disorderKavita Gajria, Mark Kosinski, Vanja Sikirica, et al.
Pageof 12